» Articles » PMID: 29632006

Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples

Abstract

Offering self-sampling of cervico-vaginal material for high-risk human papillomavirus (hrHPV) testing is an effective method to increase the coverage in cervical screening programs. Molecular triage directly on hrHPV-positive self-samples for colposcopy referral opens the way to full molecular cervical screening. Here, we set out to identify a DNA methylation classifier for detection of cervical precancer (CIN3) and cancer, applicable to lavage and brush self-samples. We determined genome-wide DNA methylation profiles of 72 hrHPV-positive self-samples, using the Infinium Methylation 450K Array. The selected DNA methylation markers were evaluated by multiplex quantitative methylation-specific PCR (qMSP) in both hrHPV-positive lavage ( = 245) and brush ( = 246) self-samples from screening cohorts. Subsequently, logistic regression analysis was performed to build a DNA methylation classifier for CIN3 detection applicable to self-samples of both devices. For validation, an independent set of hrHPV-positive lavage ( = 199) and brush ( = 287) self-samples was analyzed. Genome-wide DNA methylation profiling revealed 12 DNA methylation markers for CIN3 detection. Multiplex qMSP analysis of these markers in large series of lavage and brush self-samples yielded a 3-gene methylation classifier ( and ). This classifier showed a very good clinical performance for CIN3 detection in both lavage (AUC = 0.88; sensitivity = 74%; specificity = 79%) and brush (AUC = 0.90; sensitivity = 88%; specificity = 81%) self-samples in the validation set. Importantly, all self-samples from women with cervical cancer scored DNA methylation-positive. By genome-wide DNA methylation profiling on self-samples, we identified a highly effective 3-gene methylation classifier for direct triage on hrHPV-positive self-samples, which is superior to currently available methods. .

Citing Articles

Identification of a novel hypermethylation marker, ZSCAN18, and construction of a diagnostic model in cervical cancer.

Yang J, Chen S, Liu Y, Wang P, Zhao J, Yi J Clin Transl Oncol. 2025; .

PMID: 39969762 DOI: 10.1007/s12094-025-03864-7.


Clinical indications for host-cell DNA methylation markers in cervical screening and management of cervical intraepithelial neoplasia: A review.

Dick S, Heideman D, Berkhof J, Steenbergen R, Bleeker M Tumour Virus Res. 2024; 19():200308.

PMID: 39694193 PMC: 11728911. DOI: 10.1016/j.tvr.2024.200308.


Colposcopy referrals and CIN3 detection after triage by host cell DNA methylation and/or HPV genotyping in HPV positive women with low-grade cytology from a population-based Dutch primary HPV screening trial.

Verhoef L, Bleeker M, Polman N, Kroon K, Steenbergen R, Ebisch R Int J Cancer. 2024; 156(5):1065-1073.

PMID: 39686532 PMC: 11701402. DOI: 10.1002/ijc.35289.


Recurrent cervical cancer detection using DNA methylation markers in self-collected samples from home.

Schaafsma M, van den Helder R, Mom C, Steenbergen R, Bleeker M, van Trommel N Int J Cancer. 2024; 156(3):659-667.

PMID: 39175103 PMC: 11621989. DOI: 10.1002/ijc.35143.


Emerging paradigms: unmasking the role of oxidative stress in HPV-induced carcinogenesis.

Letafati A, Taghiabadi Z, Zafarian N, Tajdini R, Mondeali M, Aboofazeli A Infect Agent Cancer. 2024; 19(1):30.

PMID: 38956668 PMC: 11218399. DOI: 10.1186/s13027-024-00581-8.


References
1.
Moran S, Arribas C, Esteller M . Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences. Epigenomics. 2015; 8(3):389-99. PMC: 4864062. DOI: 10.2217/epi.15.114. View

2.
Rijkaart D, Berkhof J, van Kemenade F, Coupe V, Hesselink A, Rozendaal L . Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening. Int J Cancer. 2011; 130(3):602-10. DOI: 10.1002/ijc.26056. View

3.
Boers A, Wang R, van Leeuwen R, Klip H, de Bock G, Hollema H . Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3. Clin Epigenetics. 2016; 8:29. PMC: 4784352. DOI: 10.1186/s13148-016-0196-3. View

4.
Hesselink A, Heideman D, Steenbergen R, Gok M, van Kemenade F, Wilting S . Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy. Int J Cancer. 2014; 135(4):880-6. DOI: 10.1002/ijc.28723. View

5.
De Strooper L, Verhoef V, Berkhof J, Hesselink A, de Bruin H, van Kemenade F . Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women. Gynecol Oncol. 2016; 141(2):341-347. PMC: 4851217. DOI: 10.1016/j.ygyno.2016.02.012. View